National Association of Testing Authorities, Australia
Scope of Accreditation
Queen Elizabeth Hospital
Site
Department of Pathology
Accreditation No.
14238
Site No.
14231
Date of Accreditation
26 Jun 2001
Address
Rm 202, Block M, Queen Elizabeth Hospital, 30 Gascoigne Road, Kowloon
0
Hong Kong
Contact
Availability
Services available to external clients
Supervision
Not Applicable
Scope of Accreditation
Withdrawn
ISO 15189 (2012)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
|
||
Service | Product | Determinant |
---|---|---|
Anatomical pathology - Cytopathology - Cervical cytological investigation for abnormalities, precancerous or cancerous changes or conditions | Liquid based cytology specimens from cervix | Cytological examination; Review and reporting of cervical cytological material |
Anatomical pathology - Cytopathology - Gynaecological (non-cervical) cytological investigation for abnormalities, precancerous or cancerous changes or conditions | Vaginal tissue | Cytological examination; Review and reporting of gynaecological (non-cervical tissue) cytological samples |
Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of body fluids, exudates, washings and brushings from non-squamous mucosal sites for the detection of malignancy | Cerebrospinal fluid (CSF); Other body fluids; Sputum; Urine; Washings or brushings from other sites | Cytological examination; Review and reporting of cytology samples |
Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of nipple discharge or smears from squamous mucosal sites for the detection of cancerous or precancerous changes | Nipple discharge | Cytological examination; Review and reporting of cytology samples |
Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations on samples obtained via fine needle aspiration biopsy | Fine needle aspirates (FNA) | Cytological examination; Review and reporting of fine needle aspiration samples |
Anatomical pathology - Tissue pathology - Coronial autopsy services | Body; Body parts | Autopsy service and reporting |
Anatomical pathology - Tissue pathology - Examination of biopsy material | Formalin fixed tissue; Fresh tissue | Review and reporting of biopsy material to identify or exclude morphological abnormalities |
Anatomical pathology - Tissue pathology - Examination of biopsy material by electron microscopy | Formalin fixed tissue; Fresh tissue; Smears | Review and reporting of biopsy material to identify or exclude ultra-structural morphological abnormalities |
Anatomical pathology - Tissue pathology - Gene probes using paraffin fluorescence in-situ hybridisation (FISH) | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of nucleic acid targets - Various |
Anatomical pathology - Tissue pathology - Gene probes using paraffin in-situ hybridisation techniques (chromogenic/silver) | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of nucleic acid targets - Various |
Detection of nucleic acid targets - Various | ||
Anatomical pathology - Tissue pathology - Immediate frozen section diagnosis | Fresh tissue | Intra-operative consultation and examination of biopsy material |
Anatomical pathology - Tissue pathology - Immunohistochemical (immunofluorescence) investigation | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of antigenic targets - Various |
Frozen tissue | Detection of antigenic targets - Various | |
Anatomical pathology - Tissue pathology - Mortuary facilities | Body; Body parts | Assessment - Level 2 mortuary |
Anatomical pathology - Tissue pathology - Non-coronial autopsy services | Body; Body parts | Autopsy service and reporting |
Chemical pathology - Analysis of calculus | Calculi | Ammonium; Calcium; Cysteine; Magnesium; Oxalate; Phosphate; Uric acid |
Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Blood | Cyanide |
Urine | 2-Ethyl-5-methyl-3,3-diphenylpyrrolidine (EMDP); 2-Ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP); Ecgonine methyl ester | |
Methanol | ||
Amphetamines; Buprenorphine; Caffeine; Cocaine; Fentanyl; Methadone; Methamphetamine; Morphine; Oxycodone; Phencyclidine; Propoxyphene; Salbutamol | ||
Barbiturates; Benzodiazepines; Cannabis; Cocaine; Opiates | ||
Paraquat | ||
Chemical pathology - Biochemical genetic services - Amino acid quantitation | Cerebrospinal fluid (CSF) | Alanine; Glycine; Serine |
Plasma; Urine | Alanine; Alloisoleucine; Arginine; Arginosuccinic acid; Asparagine; Aspartic acid; Citrulline; Cystine; Glutamic acid; Glutamine; Glycine; Histidine; Homocysteine; Hydroxyproline; Isoleucine; Leucine; Lysine; Methionine; Ornithine; Phenylalanine; Phosphoethanolamine; Proline; Serine; Taurine; Threonine; Tryptophan; Tyrosine; Valine; α-Aminobutyric acid | |
Chemical pathology - Biochemical genetic services for the diagnosis of metabolic and enzymological disorders | Urine | 2,4-Dinitrophenylhydrazine (DNPH, Brady's reagent, Borche's reagent); Chyle; D-lactate; Ferric chloride; Indican; Mucopolysaccharides (MPS); Sulfite |
Chemical pathology - Biogenic amines | Plasma | Metanephrine; Methoxytyramine; Normetanephrine |
Urine | 5-Hydroxyindoleacetic acid (5-HIAA); Adrenaline; Dopamine; Homovanillic acid (HVA); Metanephrine; Methoxytyramine; Noradrenaline; Normetanephrine; Vanillylmandelic acid (VMA) | |
Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Blood | Cyclosporin; Everolimus; Sirolimus; Tacrolimus |
Serum | Carbamazepine; Digoxin; Gentamicin (cidomycin, septopal, genticyn, garamycin); Phenobarbitone; Phenytoin (dilantin); Theophylline; Valproate (valproic acid, epilim); Vancomycin | |
Amikacin | ||
Methotrexate | ||
Lithium | ||
Ethanol; Paracetamol (acetaminophen); Salicylate | ||
Urine | 1,4-Dibenzylpiperazine (DBZP); 3',4'-Methylenedioxy-α-pyrrolidinobutyrophenone (MDPBP ); 3,4-Methylenedioxy-N-ethylamphetamine (MDEA); 3,4-Methylenedioxyamphetamine (MDA); 3,4-Methylenedioxymethamphetamine (MDMA); 3,4-Methylenedioxypyrovalerone (MDPV); 3-Hydroxymorphinan; 3-Methoxymorphinan; 4-Diphenylmethoxy-1-methylpiperidine; 4-Hydroxy-3-methoxymethamphetamine (HMMA); 5-Flucytosine; 6β-Naltrexol; Acebutolol; Acepromazine; Acetazolamide; Acyclovir; Adrenalone; Alfentanil; Allopurinol; Alprazolam; Alprenolol; Amantadine; Ambroxol; Amiloride; Amiodarone; Amisulpride; Amitriptyline; Amlodipine; Amobarbital; Amoxapine; Amoxicillin; Antazoline; Apomorphine; Aripiprazole; Atenolol; Atomoxetine; Atropine; Azithromycin; Baclofen; Barbital; Benfluorex; Benzoylecgonine (ecgonine benzoate); Benzylpiperazine (BZP, 1-benzylpiperazine); Betamethasone; Betaxolol; Bisacodyl - Cathartic; Bisoprolol; Bromazepam; Bromhexine; Bromocriptine; Bromperidol; Brompheniramine; Buflomedil; Bufotenine; Bumetanide; Bupivacaine; Bupropion; Buspirone; Butoforme; Butorphanol; Captopril; Carbamazepine; Carbimazole; Carbinoxamine; Carvedilol; Cathinone (benzoylethanamine, β-keto-amphetamine); Cefotaxime; Cefuroxime; Celecoxib; Cetirizine; Chlordiazepoxide; Chloroquine; Chlorothiazide; Chlorpheniramine; Chlorpromazine; Chlorpropamide; Chlorprothixene; Cimetidine; Cinchonine; Ciproflocaxin; Citalopram; Clarithromycin; Clenbuterol; Clobazam; Clomipramine; Clonazepam; Clonidine; Clozapine; Cocaethylene; Codeine; Colchicine; Cotinine; Crimidine; Cyproheptadine; Dapsone; Dehydronifedipine (DHN); Dehydronifedipinic acid (DHNA); Desipramine; Dexamethasone; Dexchlorpheniramine; Dextromethorphan; Dextromoramide; Dextrorphan; Diazepam; Dibucaine (cinchocaine); Diclofenac; Dihydrocodeine (6α-hydrocodol); Diisopyramide; Diltiazem; Diphenhydramine; Dipyridamole; Domperidone; Donepezil; Dothiepin (dosulepin); Doxepin; Doxylamine; Duloxetine; Empagliflozin; Enalapril; Entacapone; Ephedrine; Ergine (LSA, d-lysergic acid amide); Ergotamine; Erythromycin; Escitalopram; Esomeprazole; Estazolam; Ethambutol; Etoricoxib; Famotidine; Felbamate; Fenfluramine; Fexofenadine; Finasteride; Flecainide; Flucloxacillin; Fluconazole; Flunitrazepam; Fluoxetine; Fluphenazine; Flurazepam; Fluvoxamine; Furosemide; Gabapentin; Glafenine; Glibenclamide; Gliclazide; Glimepiride; Glipizide; Guaifenesin; Haloperidol; Heroin; Hydrochlorothiazide; Hydrocodone; Hydromorphone; Hydroxychloroquine; Hydroxyzine; Hyoscine (scopolamine); Ibuprofen; Ifendopril; Imipramine; Indapamide; Indomethacin; Irbesartan; Isoniazid; Isoprenaline; Ketamine; Ketobemidone; Ketoconazole; Ketoprofen; Labetalol; Lacosamide; Lamotrigine; Lansoprazole; Laudanosine; Levamisole; Levetiracetam; Levofloxacin; Levomepromazine; Lidocaine; Lisinopril; Loperamide; Loratadine; Lorazepam; Lormetazepam; Losartan; Loxapine; Lysergic acid diethylamide (LSD, lysergide); Mannitol; Maprotiline; Mefenamic acid; Melitracen (flupentixol); Meloxicam; Memantine; Meperidine (pethidine); Mephedrone; Mepyramine; Metformin; Methaqualone; Methoxyphenamine (OMMA); Methylbenzodioxolylbutanamine (MBDB); Methyldopa; Methylhexanamine (dimethylamylamine); Methylphenidate; Metoclopramide; Metolazone; Metoprolol; Metronidazole; Mianserin; Midazolam; Minaprine; Mirtazapine; Misoprostol; Monoethylglycinexylidide (MEGX); N-Methylephedrine; Nadolol; Nalbuphine; Naloxone; Naltrexone; Naproxen; Nateglinide; Nicotine; Nifedipine; Nimetazepam; Nimodipine; Nitrazepam; Nortriptyline; Olanzapine; Omeprazole; Orphenadrine; Oxazepam; Oxazepam glucuronide; Oxcarbazepine; Oxybutynin; Oxymorphone; Paliperidone; Pantoprazole; Papaverine; Paracetamol (acetaminophen); Paroxetine; Pentazocine; Pericyazine; Perindopril; Perphenazine; Phenformin; Pheniramine; Phenobarbital; Phentermine; Phenylephrine; Phenylpropanolamine (PPA); Phenytoin (dilantin); Pholcodine; Pimozide; Pioglitazone; Piroxicam; Pizotifen; Posaconazole; Prazepam; Prazosin; Pregabalin; Primaquine; Procaine; Prochlorperazine; Profenamine (ethopropazine); Proguanil; Promethazine; Propafenone; Propranolol; Protriptyline; Pseudoephedrine (PSE); Pyrazinamide; Pyrimethamine; Quetiapine; Quinidine; Quinine; Ramipril; Ranitidine; Reboxetine; Repaglinide; Rifampicin; Risperidone; Rivastigmine; Rosiglitazone; Roxithromycin; Rufinamide; Secobarbital; Selegiline; Sertraline; Sibutramine; Sildenafil; Simvastatin; Sotalol; Spironolactone; Sufentanil; Sulfamethoxazole; Sulfasalazine; Sulindac; Sulpiride; Telmisartan; Temazepam; Tenoxicam; Terazosin; Terbutaline; Tetracaine; Tetrahydropalmatine; Tetrazepam; Thiopental; Thioridazine; Tiagabine; Tianeptine; Tiapride; Ticlopidine; Tiotixene (thiothixene); Tolazamide; Tolbutamide; Tolterodine; Topiramate; Tramadol; Trazodone; Triamterene; Triazolam; Trifluoperazine; Trifluoromethylphenylpiperazine (TFMPP); Trihexyphenidyl (benzhexol); Trimetazidine; Trimethoprim; Trimipramine; Valsartan; Venlafaxine; Verapamil; Vigabatrin; Voriconazole; Warfarin; Zaleplon; Ziprasidone; Zolpidem; Zonisamide; Zopiclone; Zuclopenthixol; m-Chlorophenylpiperazine (m-CPP); para-Methoxy-N-methylamphetamine; para-Methoxyamphetamine | |
Chemical pathology - Detection and/or quantitation of tumour markers | Serum | CA125 antigen (CA125); CA19-9 antigen (CA19-9); CYFRA 21-1; Carcinoembryonic antigen (CEA); Human chorionic gonadotropin (hCG); Prostate specific antigen (PSA); α-Fetoprotein (AFP) |
Thyroglobulin | ||
Chemical pathology - Detection of faecal occult blood | Faeces | Blood |
Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Blood | Adrenocorticotropic hormone (ACTH) |
Plasma | Renin | |
Saliva | Cortisol | |
Serum | Calcitonin; Gastrin; Growth hormone | |
Aldosterone | ||
Procalcitonin | ||
Cortisol; Dehydroepiandrosterone sulfate (DHEAS); Follicle stimulating hormone (FSH); Insulin; Luteinising hormone (LH); Oestradiol; Parathyroid hormone (PTH); Progesterone; Prolactin; Sex hormone binding globulin (SHBG); Testosterone; Testosterone - Free | ||
11-Deoxycortisol; 17α-Hydroxyprogesterone; Androstenedione; Testosterone | ||
Urine | 11-oxo-Etiocholanolone; 11-oxo-Pregnanetriol; 11β-Hydroxyandrosterone; 11β-Hydroxyetiocholanolone; 16α-Hydroxydehydroepiandrosterone; 16α-Hydroxypregnenolone; 17α-Hydroxypregnenolone; 17β-Androstenediol; 3a,16a,20a Pregnanetriol; 3b,16a,20a Pregnanetriol; Allotetrahydrocorticosterone; Allotetrahydrocortisol; Androstenetriol; Androsterone; Cortisol; Dehydroepiandrosterone (DHEA); Etiocholanolone; Pregnanediol; Pregnanetriol; Tetrahydro-11-dehydrocorticosterone; Tetrahydro-11-deoxycortisol; Tetrahydrocorticosterone; Tetrahydrocortisol; Tetrahydrocortisone; α-Cortol; α-Cortolone; β-Cortol; β-Cortolone | |
Chemical pathology - Diagnosis and management of diabetes mellitus | Urine | Ketones |
Chemical pathology - Further investigation of cardiac function | Plasma | Troponin |
Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia | Plasma | HDL - Quantitation |
Chemical pathology - Further investigation of renal and/or hepatic function | Plasma; Urine | Uric acid |
Serum | Alkaline phosphatase (ALP) isoenzymes | |
Indocyanine green clearance | ||
Caeruloplasmin; Haptoglobins; α1-Antitrypsin | ||
Chemical pathology - Haem related pigments and precursors (excluding porphyria) | Cerebrospinal fluid (CSF) | Xanthochromia |
Faeces | Stercobilinogen | |
Urine | Haemoglobin (Hb); Myoglobin | |
Bilirubin | ||
Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Cerebrospinal fluid (CSF) | Lactate; Protein - Total |
Glucose | ||
Muscle | Adenosine triphosphate; NADH-tetrazolium reductase; Non-specific esterase; Phosphorylase; Succinic dehyrogenase | |
Other body fluids; Urine | pH | |
Plasma | Alanine aminotransferase; Alkaline phosphatase; Amylase; Aspartate aminotransferase; Bicarbonate; Bilirubin - Total; Calcium - Total; Cholesterol - Total; Creatine kinase; Creatinine; Glucose; Lactate dehydrogenase (LDH); Phosphate; Protein - Total; Triglycerides; Urea; γ-Glutamyltransferase | |
Ammonia; Bilirubin - Any fractions; Creatinine; Lactate; Magnesium | ||
Plasma; Urine | Chloride; Potassium; Sodium | |
Osmolality | ||
Pleural fluid | pH | |
Rectal biopsy | Acetylcholinesterase (RCAC) | |
Serum | C-reactive protein (CRP); High sensitivity C-reactive protein (CRP) | |
Cholinesterase | ||
Urine | Urobilinogen | |
Albumin; Creatinine; Microalbumin; Protein - Total | ||
Amylase; Calcium - Total; Creatinine; Phosphate; Urea | ||
Creatinine; Lactate | ||
Chemical pathology - Investigation for folate deficiency | Serum | Folate |
Chemical pathology - Investigation of malabsorption | Urine | Reducing substances |
Chemical pathology - Investigation of porphyria | Urine | Coproporphobilinogen; Uroporphobilinogen |
Porphobilinogen (PBG) | ||
Chemical pathology - Iron studies | Serum | Iron; Total iron-binding capacity (TIBC) |
Ferritin | ||
Chemical pathology - Markers of bone metabolism | Serum | Procollagen type 1 N-terminal propeptide (P1NP); β-Crosslaps (CTX) |
Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Bicarbonate; Calcium - Ionised; Carboxyhaemoglobin; Haemoglobin (Hb); Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); pH |
Chemical pathology - Quantitation of precursor and intermediary metabolites | Blood | Pyruvate |
Serum | β-Hydroxybutyrate | |
Chemical pathology - Quantitation of vitamins | Blood | 25-Hydroxyvitamin D |
Serum | Cobalamin (vitamin B12) | |
Chemical pathology - Tests for thyroid function | Serum | Thyroid stimulating hormone (TSH); Thyroxine (T4) - Free; Triiodothyronine (T3) - Free |
Chemical pathology - Trace element analysis | Blood | Arsenic; Cadmium; Chromium; Cobalt; Lead; Manganese |
Plasma | Aluminium; Chromium; Cobalt; Manganese; Selenium; Vanadium | |
Serum | Copper; Zinc | |
Urine | Aluminium; Antimony; Arsenic; Cadmium; Copper; Nickel; Vanadium | |
Cytogenetics - Detection of defined, balanced and/or unbalanced chromosomal abnormalities by in-situ hybridisation techniques | Blood; Bone marrow | Cytogenetic analysis and reporting |
Cytogenetics - Molecular karyotype (SNP microarray) detection of unbalanced chromosome abnormalities | Bone marrow | Cytogenetic analysis and reporting |
Haematology - Assessment of haemolysis or metabolic enzymes (red cell enzyme assays) | Blood | Glucose-6-phosphate dehydrogenase (G6PD) |
Haematology - Bone marrow examination | Bone marrow | Examination of aspirated material |
Haematology - Diagnosis of thalassemia | Blood | Haemoglobin A2 (HbA2) - Quantitation; Haemoglobin F (HbF) - Quantitation |
Haematology - Examination of blood films by special staining | Blood | Haemoglobin H; Heinz bodies |
Malaria | ||
Acid phosphatase; Lipids/triglycerides; Myeloid differentiation; Myeloperoxidase; Non-specific esterase; Polysaccharides | ||
Haematology - Foetal haemoglobin in maternal circulation | Blood | Detection and quantitation of foetal red cell antigens |
Haematology - Full blood examination | Blood | Differential number; Morphology; Reticulocytes |
Differential number; Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Platelet count; Red blood cell index or indices; Reticulocytes | ||
Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Plasma | Activated partial thromboplastin time (APTT); Anti-thrombin III; Factor II; Factor IX; Factor V; Factor VII; Factor VIII; Factor X; Factor XI; Factor XII; Fibrinogen; Mixing studies - APTT; Protein C and protein S; Prothrombin time (PT); Thrombin time (TT) |
D-dimer | ||
Lupus anticoagulant | ||
Haematology - Investigation of haemoglobinopathy (excluding thalassemia) | Blood | Haemoglobin instability |
Haemoglobin S (HbS) - Presence | ||
Other abnormal haemoglobins | ||
Haemoglobin fraction (S, C, D, E) - Quantitation | ||
Haematology - Investigation of haemolysis | Blood | Schumm’s test |
Paroxysmal nocturnal haemoglobinuria (PNH) screen | ||
Osmotic fragility | ||
Cold agglutinins | ||
Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
Immunohaematology - Blood group antibody detection | Blood | Other blood group systems; Rh phenotypes |
Immunohaematology - Blood grouping | Blood | ABO; RhD |
Immunohaematology - Determination of compatibility of blood donor units | Blood | Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies |
Immunohaematology - Identification and quantitation of blood group antibodies | Blood | Antibody titration |
Red blood cell phenotyping | ||
Other blood group antibodies; Rh | ||
Antibody elution | ||
Immunohaematology - Investigation of blood transfusion reactions | Blood | Direct antiglobulin test (DAT, direct Coombs test); Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies |
Immunohaematology - Issue and release of blood and blood product for transfusion | Blood | Issue and release of blood and blood products for transfusion |
Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping) | Blood; Bone marrow | CD10; CD13; CD2; CD20; CD22; CD3; CD33; CD5; CD7; CD79a; Myeloperoxidase |
Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Serum | Anti-cardiolipin antibodies (ACA); Anti-double stranded DNA antibodies (dsDNA); Anti-extractable nuclear antigen antibodies (ENA); Anti-myeloperoxidase antibodies (MPO); Anti-neutrophil cytoplasmic antibodies (ANCA); Anti-nuclear antibodies (ANA); Anti-thyroglobulin antibodies (Tg); Anti-thyroid peroxidase antibodies (TPO) |
Rheumatoid factor | ||
Anti-gastric parietal cell antibodies (GPC/PCA); Anti-mitochondrial antibodies (AMA, AMA M1 and/or AMA M2); Anti-smooth muscle antibodies (SMA); Anti-striated muscle antibodies | ||
Immunopathology - Quantitation of complement proteins | Serum | Complement components C3 and C4 |
Immunopathology - Quantitative and/or qualitative investigation of proteins | Serum | Detection and quantitation of free kappa and free lambda light chains |
Cryoglobulins | ||
Serum; Urine | Protein classes | |
Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses | Serum | Total immunoglobulin A; Total immunoglobulin G; Total immunoglobulin M |
Microbiology - Bacteriology - Detection of pathogenic bacteria | Blood | Bacteria; Pathogenic microorganisms |
Blood; Cerebrospinal fluid (CSF); Faeces; Fluids; General swabs; Genital swabs; Nasal swabs; Rectal swabs; Respiratory specimens; Sputum; Throat swabs; Tissues; Urine; Vaginal swabs | Bacteria; Casts; Crystals; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | |
Bacteria; Pathogenic identification; Pathogenic microorganisms | ||
Bacteria; Pathogenic identification; Pathogenic microorganisms | ||
Antibiotic susceptibility; Bacteria; Pathogenic microorganisms | ||
Bacteria; Pathogenic microorganisms | ||
Cerebrospinal fluid (CSF); Fluids | Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | |
Faeces | Clostridioides difficile toxin; Clostridium difficile glutamate dehydrogenase | |
Urine | Legionella antigen; Streptococcus pneumoniae antigen | |
Specific gravity | ||
Glucose; Proteins | ||
Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Faeces | Clostridioides difficile |
Nasal swabs | Methicillin resistant Staphylococcus aureus (MRSA) | |
Nasopharyngeal aspirate; Sputum | Chlamydophila pneumoniae; Mycoplasma pneumoniae | |
Sputum | Legionella pneumophila | |
Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Blood; Cerebrospinal fluid (CSF) | Human immunodeficiency virus type 1 (HIV-1) RNA |
Hepatitis B virus (HBV) DNA | ||
Liquid based cytology specimens | Human papilloma virus (HPV) | |
Microbiology - Mycobacteriology - Detection and identification of mycobacteria | Aspirates; Blood; Bone marrow; Bronchial washings; Bronchoalveolar lavage; Cerebrospinal fluid (CSF); Faeces; Gastric lavage; Other body fluids; Respiratory specimens; Skin swabs; Sputum; Tissues; Urine; Wound swabs | Mycobacteria identification |
Aspirates; Blood; Bone marrow; Bronchial washings; Bronchoalveolar lavage; Cerebrospinal fluid (CSF); Faeces; Gastric lavage; Other body fluids; Skin swabs; Sputum; Tissues; Urine; Wound swabs | Mycobacteria identification | |
Microbiology - Mycobacteriology - Tests for antigen lymphocyte stimulation | Blood | Mycobacterial antigen lymphocyte stimulation |
Microbiology - Mycology - Detection, isolation and/or identification of yeasts and/or fungal elements | Cerebrospinal fluid (CSF); Faeces; Fluids; General swabs; Genital swabs; Nails; Nasal swabs; Respiratory specimens; Respiratory swabs; Skin scrapings; Sputum; Throat swabs; Tissues; Urine; Vaginal swabs | Fungi identification; Yeasts identification |
Fungi identification; Yeasts identification | ||
Cerebrospinal fluid (CSF); Serum | Cryptococcus antigen | |
Hair; Nails; Skin scrapings | Fungi identification; Yeasts identification | |
Isolates; Nails; Respiratory swabs; Skin scrapings; Sputum | Fungi susceptibility; Yeast susceptibility | |
Microbiology - Parasitology - Detection of ova, cysts and parasites | AspiratesLiver aspiration; duodenal aspiration; sigmoidoscopy specimens | Cysts; Ova; Parasites |
Blood | Malaria | |
Corneal scrapings; Faeces | Amoebae | |
Corneal scrapingsContact lens solution; contact lens | Acanthamoeba spp. | |
Faeces | Cryptosporidia | |
Cryptosporidia; Isospora spp. | ||
Giardia spp. | ||
Faeces; Urine | Cysts; Ova; Parasites | |
Skin scrapings | Scabies | |
Sputum | Cysts; Ova; Parasites | |
Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Blood | Infectious mononucleosis |
Serum | Syphilis Treponema pallidum antibody | |
Cytomegalovirus (CMV) IgG avidity; Cytomegalovirus antibody (anti-CMV) IgM; Hepatitis A virus antibody (anti-HAV) - IgM; Hepatitis B virus core antibody (anti-HBc) - IgM; Hepatitis B virus core antibody (anti-HBc) - Total; Hepatitis B virus envelope antibody (anti-HBe); Hepatitis B virus envelope antigen (HBe Ag); Hepatitis B virus surface antibody (anti-HBs); Hepatitis B virus surface antigen (HBs Ag); Human immunodeficiency virus (HIV); Measles IgG antibody; Mumps virus IgG antibody; Rubella IgG antibody; Rubella IgM antibody; Toxoplasma spp. IgM antibody; Varicella zoster virus (VZV) IgG antibody | ||
Hepatitis C virus (HCV) | ||
Hepatitis A virus antibody (anti-HAV) - IgG; Hepatitis B virus envelope antigen (HBe Ag); Hepatitis B virus surface antibody (anti-HBs); Hepatitis B virus surface antigen (HBs Ag); Hepatitis C virus (HCV); Human immunodeficiency virus (HIV); Syphilis Treponema pallidum antibody | ||
Hepatitis E virus (HEV) IgM | ||
Hepatitis D virus (HDV) | ||
Hepatitis B virus surface antigen (HBs Ag); Hepatitis C virus (HCV); Human immunodeficiency virus (HIV) | ||
Measles IgG antibody; Varicella zoster virus (VZV) IgG antibody | ||
Anti-streptolysin O (ASOT) | ||
Epstein-Barr virus viral capsid antigen | ||
Brucella spp. | ||
β-1,3-D-Glucan | ||
Human immunodeficiency virus (HIV) | ||
Syphilis Treponema pallidum antibody | ||
Human immunodeficiency virus (HIV); Measles IgG antibody; Mumps virus IgG antibody; Varicella zoster virus (VZV) IgG antibody | ||
Microbiology - Virology - Detection of pathogenic viruses | Aspirates; Bronchoalveolar lavage; Nasopharyngeal aspirate; Nasopharyngeal swabs; Respiratory swabs and/or washings | Adenovirus; Influenza A virus; Influenza B virus; Parainfluenza virus; Respiratory syncytial virus (RSV) |
Faeces | Rotavirus | |
Nasopharyngeal aspirate; Nasopharyngeal swabs | Influenza A virus; Influenza B virus | |
Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genes | Blood | Blood borne tumours |
Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted genes | Aspirates; Formalin-fixed paraffin-embedded (FFPE) tissues; Sputum | EGFR mutation analysisEGFR |
Molecular genetics - Investigation of constitutional genetic variants - Carrier testing - Targeted genes | Blood | α-Thalassaemia |
Molecular genetics - Investigation of constitutional genetic variants - Diagnostic testing - Targeted genes | Blood; Bone marrow; Leucocytes (leukocytes) | α-ThalassaemiaJAK2 mutation analysis |
ISO 15189 (2012)
Human Pathology
|
||
Service | Product | Determinant |
---|---|---|
Anatomical pathology - Cytopathology - Cervical cytological investigation for abnormalities, precancerous or cancerous changes or conditions | Liquid based cytology specimens from cervix | Cytological examination; Review and reporting of cervical cytological material |
Anatomical pathology - Cytopathology - Gynaecological (non-cervical) cytological investigation for abnormalities, precancerous or cancerous changes or conditions | Vaginal smears | Cytological examination; Review and reporting of gynaecological (non-cervical tissue) cytological samples |
Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of body fluids, exudates, washings and brushings from non-squamous mucosal sites for the detection of malignancy | Cerebrospinal fluid (CSF); Other body fluids; Sputum; Urine; Washings or brushings from other sites | Cytological examination; Review and reporting of cytology samples |
Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations on samples obtained via fine needle aspiration biopsy | Fine needle aspirates (FNA) | Cytological examination; Review and reporting of fine needle aspiration samples |
Anatomical pathology - Tissue pathology - Coronial autopsy services | Body; Body parts | Autopsy service and reporting |
Anatomical pathology - Tissue pathology - Examination of biopsy material | Formalin fixed tissue; Fresh tissue | Review and reporting of biopsy material to identify or exclude morphological abnormalities |
Anatomical pathology - Tissue pathology - Examination of biopsy material by electron microscopy | Formalin fixed tissue; Fresh tissue | Review and reporting of biopsy material to identify or exclude ultra-structural morphological abnormalities |
Anatomical pathology - Tissue pathology - Gene probes using paraffin fluorescence in-situ hybridisation (FISH) | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of nucleic acid targets - Various |
Anatomical pathology - Tissue pathology - Gene probes using paraffin in-situ hybridisation techniques (chromogenic/silver) | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of nucleic acid targets - Various |
Detection of nucleic acid targets - Various | ||
Anatomical pathology - Tissue pathology - Immediate frozen section diagnosis | Fresh tissue | Intra-operative consultation and examination of biopsy material |
Anatomical pathology - Tissue pathology - Immunohistochemical (immunofluorescence) investigation | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of antigenic targets - Various |
Frozen tissue | Detection of antigenic targets - Various | |
Anatomical pathology - Tissue pathology - Immunohistochemical investigation | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of antigenic targets - Various |
Frozen sections of fresh tissue | Detection of antigenic targets - Various | |
Anatomical pathology - Tissue pathology - Mortuary facilities | Body; Body parts | Assessment - Level 2 mortuary |
Anatomical pathology - Tissue pathology - Non-coronial autopsy services | Body; Body parts | Autopsy service and reporting |
Anatomical pathology - Tissue pathology - Skeletal muscle enzyme histochemistry | Frozen sections of skeletal muscle | Detection of muscle enzyme targets |
Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Muscle | Adenosine triphosphate; NADH-tetrazolium reductase; Non-specific esterase; Phosphorylase; Succinic dehyrogenase |
Rectal biopsy | Acetylcholinesterase (RCAC) |
ISO 15189 (2012)
Human Pathology
|
||
Service | Product | Determinant |
---|---|---|
Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Blood | Cyanide |
Urine | Methanol; Paraquat | |
Amphetamines; Buprenorphine; Caffeine; Cocaine; Fentanyl; Methadone; Methamphetamine; Morphine; Oxycodone; Phencyclidine; Propoxyphene; Salbutamol | ||
Paraquat | ||
Benzodiazepines | ||
2-Ethyl-5-methyl-3,3-diphenylpyrrolidine (EMDP); 2-Ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP); Amphetamines; Buprenorphine; Caffeine; Cocaine; Ecgonine methyl ester; Fentanyl; Methadone; Methamphetamine; Morphine; Oxycodone; Phencyclidine; Propoxyphene; Salbutamol | ||
Chemical pathology - Biochemical genetic services - Amino acid quantitation | Cerebrospinal fluid (CSF) | Alanine; Glycine; Serine |
Plasma; Urine | Alanine; Alloisoleucine; Arginine; Arginosuccinic acid; Asparagine; Aspartic acid; Citrulline; Cystine; Glutamic acid; Glutamine; Glycine; Histidine; Homocysteine; Hydroxyproline; Isoleucine; Leucine; Lysine; Methionine; Ornithine; Phenylalanine; Phosphoethanolamine; Proline; Serine; Taurine; Threonine; Tryptophan; Tyrosine; Valine; α-Aminobutyric acid | |
Chemical pathology - Biochemical genetic services for the diagnosis of metabolic and enzymological disorders | Urine | 2,4-Dinitrophenylhydrazine (DNPH, Brady's reagent, Borche's reagent); Chyle; D-lactate; Ferric chloride; Indican; Mucopolysaccharides (MPS); Sulfite |
Chemical pathology - Biogenic amines | Plasma | Metanephrine; Methoxytyramine; Normetanephrine |
Urine | 5-Hydroxyindoleacetic acid (5-HIAA); Adrenaline; Dopamine; Homovanillic acid (HVA); Metanephrine; Methoxytyramine; Noradrenaline; Normetanephrine; Vanillylmandelic acid (VMA) | |
Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Blood | Cyclosporin; Everolimus; Sirolimus; Tacrolimus |
Serum | Methotrexate | |
Amikacin | ||
Lithium | ||
Carbamazepine; Digoxin; Gentamicin (cidomycin, septopal, genticyn, garamycin); Methotrexate; Phenobarbitone; Phenytoin (dilantin); Theophylline; Valproate (valproic acid, epilim); Vancomycin | ||
Ethanol; Paracetamol (acetaminophen); Salicylate | ||
Urine | 1,4-Dibenzylpiperazine (DBZP); 3',4'-Methylenedioxy-α-pyrrolidinobutyrophenone (MDPBP ); 3,4-Methylenedioxy-N-ethylamphetamine (MDEA); 3,4-Methylenedioxyamphetamine (MDA); 3,4-Methylenedioxymethamphetamine (MDMA); 3,4-Methylenedioxypyrovalerone (MDPV); 3-Hydroxymorphinan; 3-Methoxymorphinan; 4-Diphenylmethoxy-1-methylpiperidine; 4-Hydroxy-3-methoxymethamphetamine (HMMA); 5-Flucytosine; 6β-Naltrexol; Acebutolol; Acepromazine; Acetazolamide; Acyclovir; Adrenalone; Alfentanil; Allopurinol; Alprazolam; Alprenolol; Amantadine; Ambroxol; Amiloride; Amiodarone; Amisulpride; Amitriptyline; Amlodipine; Amobarbital; Amoxapine; Amoxicillin; Antazoline; Apomorphine; Aripiprazole; Atenolol; Atomoxetine; Atropine; Azithromycin; Baclofen; Barbital; Benfluorex; Benzoylecgonine (ecgonine benzoate); Benzylpiperazine (BZP, 1-benzylpiperazine); Betamethasone; Betaxolol; Bisacodyl - Cathartic; Bisoprolol; Bromazepam; Bromhexine; Bromocriptine; Bromperidol; Brompheniramine; Buflomedil; Bufotenine; Bumetanide; Bupivacaine; Bupropion; Buspirone; Butoforme; Butorphanol; Captopril; Carbamazepine; Carbimazole; Carbinoxamine; Carvedilol; Cathinone (benzoylethanamine, β-keto-amphetamine); Cefotaxime; Cefuroxime; Celecoxib; Cetirizine; Chlordiazepoxide; Chloroquine; Chlorothiazide; Chlorpheniramine; Chlorpromazine; Chlorpropamide; Chlorprothixene; Cimetidine; Cinchonine; Ciproflocaxin; Citalopram; Clarithromycin; Clenbuterol; Clobazam; Clomipramine; Clonazepam; Clonidine; Clozapine; Cocaethylene; Codeine; Colchicine; Cotinine; Crimidine; Cyproheptadine; Dapsone; Dehydronifedipine (DHN); Dehydronifedipinic acid (DHNA); Desipramine; Dexamethasone; Dexchlorpheniramine; Dextromethorphan; Dextromoramide; Dextrorphan; Diazepam; Dibucaine (cinchocaine); Diclofenac; Dihydrocodeine (6α-hydrocodol); Diisopyramide; Diltiazem; Diphenhydramine; Dipyridamole; Domperidone; Donepezil; Dothiepin (dosulepin); Doxepin; Doxylamine; Duloxetine; Empagliflozin; Enalapril; Entacapone; Ephedrine; Ergine (LSA, d-lysergic acid amide); Ergotamine; Erythromycin; Escitalopram; Esomeprazole; Estazolam; Ethambutol; Etoricoxib; Famotidine; Felbamate; Fenfluramine; Fexofenadine; Finasteride; Flecainide; Flucloxacillin; Fluconazole; Flunitrazepam; Fluoxetine; Fluphenazine; Flurazepam; Fluvoxamine; Furosemide; Gabapentin; Glafenine; Glibenclamide; Gliclazide; Glimepiride; Glipizide; Guaifenesin; Haloperidol; Heroin; Hydrochlorothiazide; Hydrocodone; Hydromorphone; Hydroxychloroquine; Hydroxyzine; Hyoscine (scopolamine); Ibuprofen; Ifendopril; Imipramine; Indapamide; Indomethacin; Irbesartan; Isoniazid; Isoprenaline; Ketamine; Ketobemidone; Ketoconazole; Ketoprofen; Labetalol; Lacosamide; Lamotrigine; Lansoprazole; Laudanosine; Levamisole; Levetiracetam; Levofloxacin; Levomepromazine; Lidocaine; Lisinopril; Loperamide; Loratadine; Lorazepam; Lormetazepam; Losartan; Loxapine; Lysergic acid diethylamide (LSD, lysergide); Mannitol; Maprotiline; Mefenamic acid; Melitracen (flupentixol); Meloxicam; Memantine; Meperidine (pethidine); Mephedrone; Mepyramine; Metformin; Methaqualone; Methoxyphenamine (OMMA); Methylbenzodioxolylbutanamine (MBDB); Methyldopa; Methylhexanamine (dimethylamylamine); Methylphenidate; Metoclopramide; Metolazone; Metoprolol; Metronidazole; Mianserin; Midazolam; Minaprine; Mirtazapine; Misoprostol; Monoethylglycinexylidide (MEGX); N-Methylephedrine; Nadolol; Nalbuphine; Naloxone; Naltrexone; Naproxen; Nateglinide; Nicotine; Nifedipine; Nimetazepam; Nimodipine; Nitrazepam; Nortriptyline; Olanzapine; Omeprazole; Orphenadrine; Oxazepam; Oxazepam glucuronide; Oxcarbazepine; Oxybutynin; Oxymorphone; Paliperidone; Pantoprazole; Papaverine; Paracetamol (acetaminophen); Paroxetine; Pentazocine; Pericyazine; Perindopril; Perphenazine; Phenformin; Pheniramine; Phenobarbital; Phentermine; Phenylephrine; Phenylpropanolamine (PPA); Phenytoin (dilantin); Pholcodine; Pimozide; Pioglitazone; Piroxicam; Pizotifen; Posaconazole; Prazepam; Prazosin; Pregabalin; Primaquine; Procaine; Prochlorperazine; Profenamine (ethopropazine); Proguanil; Promethazine; Propafenone; Propranolol; Protriptyline; Pseudoephedrine (PSE); Pyrazinamide; Pyrimethamine; Quetiapine; Quinidine; Quinine; Ramipril; Ranitidine; Reboxetine; Repaglinide; Rifampicin; Risperidone; Rivastigmine; Rosiglitazone; Roxithromycin; Rufinamide; Secobarbital; Selegiline; Sertraline; Sibutramine; Sildenafil; Simvastatin; Sotalol; Spironolactone; Sufentanil; Sulfamethoxazole; Sulfasalazine; Sulindac; Sulpiride; Telmisartan; Temazepam; Tenoxicam; Terazosin; Terbutaline; Tetracaine; Tetrahydropalmatine; Tetrazepam; Thiopental; Thioridazine; Tiagabine; Tianeptine; Tiapride; Ticlopidine; Tiotixene (thiothixene); Tolazamide; Tolbutamide; Tolterodine; Topiramate; Tramadol; Trazodone; Triamterene; Triazolam; Trifluoperazine; Trifluoromethylphenylpiperazine (TFMPP); Trihexyphenidyl (benzhexol); Trimetazidine; Trimethoprim; Trimipramine; Valsartan; Venlafaxine; Verapamil; Vigabatrin; Voriconazole; Warfarin; Zaleplon; Ziprasidone; Zolpidem; Zonisamide; Zopiclone; Zuclopenthixol; m-Chlorophenylpiperazine (m-CPP); para-Methoxy-N-methylamphetamine; para-Methoxyamphetamine | |
Chemical pathology - Detection and/or quantitation of tumour markers | Serum | Thyroglobulin |
CA125 antigen (CA125); CA19-9 antigen (CA19-9); CYFRA 21-1; Carcinoembryonic antigen (CEA); Human chorionic gonadotropin (hCG); Prostate specific antigen (PSA); Thyroglobulin; α-Fetoprotein (AFP) | ||
Chemical pathology - Detection of faecal occult blood | Faeces | Blood |
Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Blood | Adrenocorticotropic hormone (ACTH) |
Plasma | Renin | |
Saliva | Cortisol; Cortisone | |
Serum | Aldosterone | |
Gastrin | ||
11-Deoxycortisol; 17α-Hydroxyprogesterone; 21-Deoxycortisol; Androstenedione; Cortisol; Testosterone | ||
Calcitonin; Cortisol; Dehydroepiandrosterone sulfate (DHEAS); Follicle stimulating hormone (FSH); Growth hormone; Insulin; Luteinising hormone (LH); Macroprolactin; Oestradiol; Parathyroid hormone (PTH); Progesterone; Prolactin; Sex hormone binding globulin (SHBG); Testosterone; Testosterone - Free | ||
Urine | 11-oxo-Etiocholanolone; 11-oxo-Pregnanetriol; 11β-Hydroxyandrosterone; 11β-Hydroxyetiocholanolone; 16α-Hydroxydehydroepiandrosterone; 16α-Hydroxypregnenolone; 17α-Hydroxypregnenolone; 17β-Androstenediol; 3a,16a,20a Pregnanetriol; 3b,16a,20a Pregnanetriol; Allotetrahydrocorticosterone; Allotetrahydrocortisol; Androstenetriol; Androsterone; Cortisol; Dehydroepiandrosterone (DHEA); Etiocholanolone; Pregnanediol; Pregnanetriol; Tetrahydro-11-dehydrocorticosterone; Tetrahydro-11-deoxycortisol; Tetrahydrocorticosterone; Tetrahydrocortisol; Tetrahydrocortisone; α-Cortol; α-Cortolone; β-Cortol; β-Cortolone | |
Cortisol | ||
Chemical pathology - Diagnosis and management of diabetes mellitus | Serum | Fructosamine |
Urine | Ketones | |
Chemical pathology - Further investigation of cardiac function | Plasma | Troponin I |
Chemical pathology - Further investigation of renal and/or hepatic function | Serum | Alkaline phosphatase (ALP) isoenzymes; Caeruloplasmin; Haptoglobins; α1-Antitrypsin |
Indocyanine green clearance | ||
Alkaline phosphatase (ALP) isoenzymes | ||
Chemical pathology - Haem related pigments and precursors (excluding porphyria) | Cerebrospinal fluid (CSF) | Xanthochromia |
Faeces | Stercobilinogen | |
Plasma | Plasma free haemoglobin | |
Urine | Bilirubin; Haemoglobin (Hb); Myoglobin; Urobilinogen | |
Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Cerebrospinal fluid (CSF) | Glucose; Lactate; Protein - Total |
Glucose | ||
Other body fluids; Urine | pH | |
Plasma | Chloride; Potassium; Sodium | |
Alanine aminotransferase; Albumin; Alkaline phosphatase; Ammonia; Amylase; Aspartate aminotransferase; Bicarbonate; Bilirubin - Any fractions; Bilirubin - Total; Calcium - Total; Chloride; Cholesterol - HDL; Cholesterol - LDL; Cholesterol - Total; Creatine kinase; Creatinine; Glucose; Lactate; Lactate dehydrogenase (LDH); Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urea; Uric acid; γ-Glutamyltransferase | ||
Ammonia; Bilirubin - Any fractions; Creatinine; Lactate; Magnesium | ||
Plasma; Urine | Osmolality | |
Pleural fluid | pH | |
Serum | C-reactive protein (CRP); High sensitivity C-reactive protein (CRP) | |
Cholinesterase | ||
Urine | Amylase; Calcium - Total; Creatinine; Magnesium; Phosphate; Urea; Uric acid | |
Urobilinogen | ||
Chloride; Creatinine; Microalbumin; Potassium; Protein - Total; Sodium | ||
Lactate | ||
Chemical pathology - Investigation for folate deficiency | Serum | Folate |
Chemical pathology - Investigation of malabsorption | Urine | Reducing substances |
Chemical pathology - Investigation of porphyria | Urine | Porphobilinogen (PBG) |
Porphyrins - Total | ||
Chemical pathology - Iron studies | Serum | Ferritin; Iron; Total iron-binding capacity (TIBC) |
Ferritin | ||
Chemical pathology - Markers of bone metabolism | Serum | Procollagen type 1 N-terminal propeptide (P1NP); β-Crosslaps (CTX) |
Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Bicarbonate; Calcium - Ionised; Carboxyhaemoglobin; Haemoglobin (Hb); Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); pH |
Chemical pathology - Quantitation of precursor and intermediary metabolites | Blood | Pyruvate |
Serum | β-Hydroxybutyrate | |
Chemical pathology - Quantitation of vitamins | Blood | 25-Hydroxyvitamin D |
Serum | Cobalamin (vitamin B12) | |
Chemical pathology - Tests for thyroid function | Serum | Thyroid stimulating hormone (TSH); Thyroxine (T4) - Free; Triiodothyronine (T3) - Free |
Chemical pathology - Trace element analysis | Blood | Arsenic; Cadmium; Chromium; Cobalt; Lead; Manganese |
Plasma | Aluminium; Chromium; Cobalt; Manganese; Selenium; Vanadium | |
Serum | Copper; Zinc | |
Urine | Aluminium; Antimony; Arsenic; Cadmium; Copper; Nickel; Vanadium | |
Immunopathology - Quantitation of complement proteins | Serum | Complement components C3 and C4 |
Immunopathology - Quantitative and/or qualitative investigation of proteins | Serum | Detection and quantitation of free kappa and free lambda light chains |
Cryoglobulins | ||
Serum; Urine | Protein classes | |
Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses | Serum | Immunoglobulin subclasses |
Total immunoglobulin A; Total immunoglobulin G; Total immunoglobulin M |
ISO 15189 (2012)
Human Pathology
|
||
Service | Product | Determinant |
---|---|---|
Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
Cytogenetics - Biodosimetry-dicentric analysis | Blood | Cytogenetic dosimetry test for individual radiation dose assessment in radiation emergencies |
Cytogenetics - Detection of defined, balanced and/or unbalanced chromosomal abnormalities by in-situ hybridisation techniques | Blood; Bone marrow | Cytogenetic analysis and reporting |
Cytogenetics - Molecular karyotype (SNP microarray) detection of unbalanced chromosome abnormalities | Bone marrow | Cytogenetic analysis and reporting |
Haematology - Assessment of haemolysis or metabolic enzymes (red cell enzyme assays) | Blood | Glucose-6-phosphate dehydrogenase (G6PD) |
Haematology - Bone marrow examination | Bone marrow | Examination of aspirated material |
Haematology - Diagnosis of thalassemia | Blood | Haemoglobin A2 (HbA2) - Quantitation; Haemoglobin F (HbF) - Quantitation |
Haematology - Examination of blood films by special staining | Blood | Haemoglobin H; Heinz bodies |
Acid phosphatase; Lipids/triglycerides; Myeloid differentiation; Myeloperoxidase; Non-specific esterase; Polysaccharides | ||
Malaria | ||
Haematology - Foetal haemoglobin in maternal circulation | Blood | Detection and quantitation of foetal red cell antigens |
Haematology - Full blood examination | Blood | Differential number; Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Platelet count; Red blood cell index or indices; Reticulocytes |
Differential number; Morphology; Reticulocytes | ||
Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | Platelet function (PFA) |
Plasma | Lupus anticoagulant | |
D-dimer | ||
Activated partial thromboplastin time (APTT); Anti-thrombin III; Factor II; Factor IX; Factor V; Factor VII; Factor VIII; Factor X; Factor XI; Factor XII; Fibrinogen; Mixing studies - APTT; Protein C and protein S; Prothrombin time (PT); Thrombin time (TT) | ||
Haematology - Investigation of haemoglobinopathy (excluding thalassemia) | Blood | Haemoglobin S (HbS) - Presence |
Other abnormal haemoglobins | ||
Haemoglobin instability | ||
Haemoglobin fraction (S, C, D, E) - Quantitation | ||
Haematology - Investigation of haemolysis | Blood | Schumm’s test |
Hereditary spherocytosis; Paroxysmal nocturnal haemoglobinuria (PNH) screen | ||
Osmotic fragility | ||
Cold agglutinins | ||
Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
Immunohaematology - Blood group antibody detection | Blood | Other blood group systems; Rh phenotypes |
Immunohaematology - Blood grouping | Blood | ABO; RhD |
Immunohaematology - Determination of compatibility of blood donor units | Blood | Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies |
Immunohaematology - Identification and quantitation of blood group antibodies | Blood | Antibody titration |
Antibody elution | ||
Direct antiglobulin test (DAT, direct Coombs test); Red blood cell phenotyping | ||
Other blood group antibodies; Rh | ||
Immunohaematology - Investigation of blood transfusion reactions | Blood | Direct antiglobulin test (DAT, direct Coombs test); Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies |
Immunohaematology - Issue and release of blood and blood product for transfusion | Blood | Issue and release of blood and blood products for transfusion |
Immunohaematology - Storage and distribution of blood and blood components | Blood; Blood products | Issue and release of blood and blood products for transfusion |
Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping) | Blood; Bone marrow | CD10; CD117; CD13; CD19; CD2; CD20; CD22; CD3; CD33; CD34; CD4; CD5; CD7; CD79a; CD8; Myeloperoxidase |
Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Serum | Anti-cardiolipin antibodies (ACA); Anti-double stranded DNA antibodies (dsDNA); Anti-extractable nuclear antigen antibodies (ENA); Anti-myeloperoxidase antibodies (MPO); Anti-neutrophil cytoplasmic antibodies (ANCA); Anti-nuclear antibodies (ANA); Anti-proteinase 3 antibodies (PR3); Anti-thyroglobulin antibodies (Tg); Anti-thyroid peroxidase antibodies (TPO) |
Anti-gastric parietal cell antibodies (GPC/PCA); Anti-mitochondrial antibodies (AMA, AMA M1 and/or AMA M2); Anti-smooth muscle antibodies (SMA); Anti-striated muscle antibodies | ||
Rheumatoid factor | ||
Infertility and pregnancy tests including assisted reproductive technology - Semen analysis (other than post vasectomy) | Semen | Motility; Sperm number |
ISO 15189 (2012)
Human Pathology
|
||
Service | Product | Determinant |
---|---|---|
Infertility and pregnancy tests including assisted reproductive technology - Diagnosis of pregnancy | Urine | Human chorionic gonadotropin (hCG) |
Microbiology - Bacteriology - Detection of pathogenic bacteria | Blood | Bacteria; Pathogenic microorganisms |
Clostridioides difficile toxin | ||
Blood; Cerebrospinal fluid (CSF); Faeces; Fluids; General swabs; Genital swabs; Nasal swabs; Rectal swabs; Respiratory specimens; Sputum; Throat swabs; Tissues; Urine; Vaginal swabs | Bacteria; Casts; Crystals; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | |
Bacteria; Pathogenic identification; Pathogenic microorganisms | ||
Antibiotic susceptibility; Bacteria; Pathogenic microorganisms | ||
Bacteria; Pathogenic microorganisms | ||
Bacteria; Pathogenic identification; Pathogenic microorganisms | ||
Cerebrospinal fluid (CSF) | Bacteria; Pathogenic microorganisms | |
Cerebrospinal fluid (CSF); Fluids | Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | |
Urine | Glucose; Proteins | |
Legionella antigen; Streptococcus pneumoniae antigen | ||
Microbiology - Environmental investigations and/or infection control | Dialysis waters; Waters | Bacterial growth - Sterility; Detection and characterisation of organisms (including identification and typing) |
Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (mycobacteria) | Respiratory specimens | Mycobacterium tuberculosis complex; Mycobacterium rifampicin resistance rpoB |
Microbiology - Mycology - Detection, isolation and/or identification of yeasts and/or fungal elements | Cerebrospinal fluid (CSF); Faeces; Fluids; General swabs; Genital swabs; Nails; Nasal swabs; Respiratory specimens; Respiratory swabs; Skin scrapings; Sputum; Throat swabs; Tissues; Urine; Vaginal swabs | Fungi identification; Yeasts identification |
Fungi identification; Yeasts identification | ||
Cerebrospinal fluid (CSF); Serum | Cryptococcus antigen | |
Hair; Nails; Skin scrapings | Fungi identification; Yeasts identification | |
Isolates; Nails; Respiratory swabs; Skin scrapings; Sputum | Fungi susceptibility; Yeast susceptibility | |
Microbiology - Parasitology - Detection of ova, cysts and parasites | AspiratesLiver aspiration; duodenal aspiration; sigmoidoscopy specimens | Cysts; Ova; Parasites |
Blood | Malaria | |
Corneal scrapings; Faeces | Amoebae | |
Corneal scrapingsContact lens solution; contact lens | Acanthamoeba spp. | |
Faeces | Cryptosporidia; Isospora spp. | |
Giardia spp. | ||
Microsporidia | ||
Faeces; Urine | Cysts; Ova; Parasites | |
Rectal swabs | Worms | |
Skin scrapings | Scabies | |
Sputum | Cysts; Ova; Parasites | |
Urine | Cysts; Ova; Parasites | |
Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Blood | Infectious mononucleosis |
Serum | Cytomegalovirus (CMV) IgG avidity; Cytomegalovirus antibody (anti-CMV) IgM; Hepatitis A virus antibody (anti-HAV) - IgM; Hepatitis B virus core antibody (anti-HBc) - IgM; Hepatitis B virus core antibody (anti-HBc) - Total; Hepatitis B virus envelope antibody (anti-HBe); Hepatitis B virus envelope antigen (HBe Ag); Hepatitis B virus surface antibody (anti-HBs); Hepatitis B virus surface antigen (HBs Ag); Human immunodeficiency virus (HIV); Measles IgG antibody; Mumps virus IgG antibody; Rubella IgG antibody; Rubella IgM antibody; Toxoplasma spp. IgM antibody; Varicella zoster virus (VZV) IgG antibody | |
Brucella spp. | ||
Hepatitis A virus antibody (anti-HAV) - IgG; Hepatitis B virus envelope antigen (HBe Ag); Hepatitis B virus surface antibody (anti-HBs); Hepatitis B virus surface antigen (HBs Ag); Hepatitis C virus (HCV); Human immunodeficiency virus (HIV); Syphilis Treponema pallidum antibody | ||
Human immunodeficiency virus (HIV) | ||
Epstein-Barr virus viral capsid antigen | ||
Hepatitis E virus (HEV) IgM | ||
Hepatitis B virus surface antigen (HBs Ag); Hepatitis C virus (HCV); Human immunodeficiency virus (HIV) | ||
Syphilis Treponema pallidum antibody | ||
Anti-streptolysin O (ASOT) | ||
Measles IgG antibody; Varicella zoster virus (VZV) IgG antibody |
ISO 15189 (2012)
Human Pathology
|
||
Service | Product | Determinant |
---|---|---|
Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (mycobacteria) | Aspirates; Respiratory specimens; Tissues | Mycobacterium tuberculosis complex |
Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Liquid based cytology specimens | Human papilloma virus (HPV) |
Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genes | Blood | Blood borne tumoursChronic myelogenous leukaemia |
Blood borne tumours | ||
Molecular genetics - DNA fragment size analysis | Blood; Formalin-fixed paraffin-embedded (FFPE) tissues | DNA fragment size determination |
Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted genes | Aspirates; Formalin-fixed paraffin-embedded (FFPE) tissues; Sputum | EGFR mutation analysisNon-small cell lung cancer (EGFR) |
EGFR mutation analysis | ||
Blood; cDNA | EGFR mutation analysis | |
Formalin-fixed paraffin-embedded (FFPE) tissues | Microsatellite instability analysis | |
Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted panels for non-inherited (somatic) DNA/RNA changes | Formalin-fixed paraffin-embedded (FFPE) tissues | KRAS mutation analysis |
Molecular genetics - Investigation of constitutional genetic variants - Carrier testing - Targeted genes | Blood; Bone marrow; Leucocytes (leukocytes) | α-ThalassaemiaJAK2 mutation analysis |
Molecular genetics - Investigation of constitutional genetic variants - Diagnostic testing - Targeted genes | Blood; Bone marrow; Leucocytes (leukocytes) | α-ThalassaemiaJAK2 mutation analysis |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
14238
Site No.
14231
Print date
29 Mar 2024